Gemeprost Versus Dinoprostone in First Trimester Miscarriages

Last updated: January 22, 2024
Sponsor: National University of Malaysia
Overall Status: Active - Recruiting

Phase

2

Condition

Miscarriage

Treatment

Gemeprost 1 Mg Vaginal Pessary

Dinoprostone 3 mg

Clinical Study ID

NCT05342467
FF-2021-504
  • Ages 18-50
  • Female
  • Accepts Healthy Volunteers

Study Summary

Comparison between gemeprost and dinoprostone to evacuate first trimester miscarriages.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • missed miscarriages
  • incomplete miscarriages
  • first trimester

Exclusion

Exclusion Criteria:

  • coagulopathy
  • Rhesus negative
  • suspected ectopic pregnancy or pregnancy of unknown location
  • on anticoagulation drug
  • septic miscarriages
  • hemodynamically unstable

Study Design

Total Participants: 174
Treatment Group(s): 2
Primary Treatment: Gemeprost 1 Mg Vaginal Pessary
Phase: 2
Study Start date:
November 11, 2021
Estimated Completion Date:
November 10, 2025

Study Description

Women who are diagnosed with first trimester missed miscarriages are invited to participate in the study. They will be randomised to either gemeprost or dinoprostone.

Connect with a study center

  • UKM Medical Center

    Kuala Lumpur, W.Persekutuan 56000
    Malaysia

    Active - Recruiting

  • UKM Medical Centre

    Kuala Lumpur, W.Persekutuan 56000
    Malaysia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.